Health
Nivolumab and Chemotherapy for Mesothelioma is Focus of New Trial – Surviving Mesothelioma
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients after surgery.
Researchers in Germany are recruiting patients for a trial of nivolumab and chemotherapy for pleural mesothelioma patients who have had surgery.
Nivolumab (Opdivo) is an immunotherapy drug similar to pembrolizumab (Keytruda). It blocks a protein that helps mesothelioma cells hide from the immune system. Nivolumab is most often used for patients with non-small cell lung cancer.
The multicenter German study will test if a combination of nivolumab and chemotherapy can help keep tumors from growing…
-
Noosa News21 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News22 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business24 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
General20 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands